Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baker Bros. Advisors | 851k | $285k | 100% | Sep 2025 |
|
| Acorn Capital Advisors | 587k | $199k | -20% | Sep 2025 |
|
| Shay Capital | 493k | $165k | 100% | Sep 2025 |
|
| Acadian Asset Management | 446k | $148k | 1891% | Sep 2025 |
|
| Ikarian Capital | 290k | $97k | 0% | Sep 2025 |
|
| Two Sigma Investments | 221k | $74k | 100% | Sep 2025 |
|
| Vanguard Group | 190k | $64k | -62% | Sep 2025 |
|
| Jane Street | 147k | $49k | 18% | Sep 2025 |
|
| Geode Capital Management | 137k | $46k | 3% | Sep 2025 |
|
| Boothbay Fund Management | 107k | $36k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 77k | $26k | 0% | Sep 2025 |
|
| Susquehanna International | 58k | $19k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 57k | $19k | 100% | Sep 2025 |
|
| Corsair Capital Management | 50k | $17k | 400% | Sep 2025 |
|
| Rangeley Capital | 50k | $17k | 100% | Sep 2025 |
|
| BlackRock | 44k | $15k | 0% | Sep 2025 |
|
| GSA Capital Partners | 36k | $12k | 167% | Sep 2025 |
|
| Northern Trust | 23k | $7.7k | 0% | Sep 2025 |
|
| Commonwealth Equity Services | 18k | $6.0k | 0% | Sep 2025 |
|
| State Street Corporation | 16k | $5.3k | 0% | Sep 2025 |
|
| Harvest Investment Services | 11k | $3.7k | -78% | Sep 2025 |
|
| UBS Group | 5.6k | $1.9k | 100% | Sep 2025 |
|
| Tower Research Capital | 3.6k | $1.2k | 28% | Sep 2025 |
|
| Morgan Stanley | 3.4k | $5.6k | 100% | Jun 2025 |
|
| Royal Bank of Canada | 2.4k | $999.912000 | 0% | Sep 2025 |
|
| Mb, Levis & Associates | 1.0k | $349.047300 | 0% | Sep 2025 |
|
| CWM | 500.00 | $0 | 0% | Sep 2025 |
|
| Centerpoint Advisors | 350.00 | $0 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 146.00 | $48.661800 | -98% | Sep 2025 |
|
| Wells Fargo & Company | 65.00 | $22.002500 | 0% | Sep 2025 |
|
| Truvestments Capital | 25.00 | $8.000000 | 0% | Sep 2025 |
|
| Newbridge Financial Services Group | 10.00 | $3.000000 | 100% | Sep 2025 |
|
Who sold out of Vyne Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cormorant Asset Management | Jun 2025 | 1.4M | $2.3M |
| Citadel Advisors | Jun 2025 | 1.0M | $1.7M |
| Adage Capital Partners GP | Jun 2025 | 644k | $1.1M |
| DAFNA Capital Management | Jun 2025 | 636k | $1.0M |
| Kennedy Capital Management | Jun 2025 | 571k | $942k |
| Palo Alto Investors | Jun 2025 | 445k | $735k |
| Patient Square Capital | Jun 2025 | 317k | $523k |
| Exome Asset Management | Jun 2025 | 209k | $345k |
| Schonfeld Strategic Advisors | Jun 2025 | 162k | $267k |
| Polygon Management | Jun 2025 | 115k | $190k |
| Squarepoint Ops | Jun 2025 | 79k | $130k |
| Springbok Capital Management | Jun 2025 | 65k | $107k |
| XTX Topco | Jun 2025 | 57k | $94k |
| Hrt Financial | Jun 2025 | 42k | $69k |
| Velan Capital Investment Management | Jun 2025 | 30k | $50k |
| Raymond James Financial | Jun 2025 | 22k | $37k |
| Renaissance Technologies | Jun 2025 | 11k | $17k |
| Northwestern Mutual Wealth Management Company | Jun 2025 | 11.00 | $18.000400 |